Laboratory PLANNING - WORKUP Blood Bank Apheresis Immunology Respiratory Dental Cardiology Radiology.

Slides:



Advertisements
Similar presentations
Acquired Aplastic Anaemia – Trends in treatment and Bone Marrow Transplantation Vikas Gupta, MD Blood and Marrow Transplant Program Princess Margaret Hospital.
Advertisements

Hematopoietic Stem Cell Transplantation Lynn Savoie September 30, 2006.
Physician Extenders in Oncology ANCO Annual Meeting 2005 Matthew Sirott MD Sarah Buenviaje ONP.
Cancer 101 Monica Schlatter, RN, ND, AOCNP. Types of Cancer AIDS- related malignancies AIDS- related malignancies Bone and soft tissue sarcoma Bone and.
Empowering hospital patients as partners in their diagnosis and treatment The example of bone marrow transplantation Hildegard Greinix Medical University.
A Project on Bone marrow HASEEB TANVEER/ FOZIA TANVEER
Transfusion Post Allogeneic Stem Cell Transplant Robert C. Skeate, MD MS.
Questions and Answers about Bone Marrow Stem Cell Transplantation prepared by the Armenian Bone Marrow Donor Registry.
BLOOD TRANSFUSION SUPPORT IN STEM CELL TRANSPLANT
Blood and marrow stem cell transplantation A.Basi ADULT HEMATOLOGIST,ONCOLOGIST IRAN UNIVERSITY OF MEDICAL SCIENCES.
Hematopoietic Stem Cell Transplantation (HSCT) Overview Willis H Navarro, MD Medical Director, Transplant Services, NMDP Associate Clinical Professor,
CHIMERISM & DLI Dr. Serdar ŞIVGIN Kayseri Feb, 2011.
NORTHEAST STATE COMMUNITY COLLEGE REGIONAL CENTER FOR HEALTH PROFESSIONS 300 WEST MAIN STREET KINGSPORT, TN.
Organ Donation & Transplantation in Ireland – Changing times Aileen Counihan Transplant Co-ordinator Beaumont Hospital Beaumont Hospital.
Fever: Nuts and Bolts Nightfloat Curriculum Lucile Packard Children’s Hospital Residency Program.
Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Doug Brutlag Professor Emeritus of.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2010 CIBMTR Summary Slides SUM10_1.ppt.
PRE-TRANSPLANT PROTOCOL STEM CELL TRANSPLANT UNIT UNIVERSITY OF BENIN TEACHING HOSPITAL.
Educational Presentation. Program Overview Provide information on The Leukemia & Lymphoma Society Describe blood cancers Explain Pennies for Patients.
Engineered Cells and Tissues Locksley McGann, PhD Professor Department of Laboratory Medicine and Pathology University of Alberta 24 April, 2012 Analytics,
Renal Transplant Patient Education
CANCER. THE WORD CANCER  FEAR  DEATH  PAIN  SUFFERING  LOSS  ECONOMIC LOSS  DISFIGUREMENT  WHAT’S THE FUTURE.
Inclusion Criteria Patient has definitive histologically or cytologically confirmed metastatic adenocarcinoma of the pancreas. The definitive diagnosis.
CMV (Cytomegalovirus) reactivation and immunosupression in allogeneic transplantation Marie Waller Bone Marrow Transplant Coordinator Manchester Royal.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Multiple Myeloma Definition:
Avoiding Protocol Violations
Transplant Creations1 Treatment & Transplant Program to improve disease outcome Transplant Creations Marlies Van Hoef.
DONOR LYMPHOCYTE INFUS I ON (DLI) Dr. Serdar ŞIVGIN February 2011 Kayseri.
PROTOCOL GO29294 A study evaluating a potential new treatment for locally advanced or metastatic urothelial bladder cancer VERSION 1 | 19 SEPTEMBER 2014.
Allogeneic “Mini” Transplantation Mark B. Juckett M.D. June 4, 2004.
Component 2: The Culture of Healthcare 3.1: Unit 3: Health Care Settings- Where Care is Delivered 3.1 e: Hospital Departments and Their Functions (Clinical)
Justin A. Crocker.  1 of the monoclonal gammopathies  Neoplastic proliferation of immunoglobulin producing plasma cells (single clone), often resulting.
Bone marrow Transplant in Paediatric Haematology
Neuroblastoma.
Educational Presentation
Hodgkin’s Lymphoma Hodgkin’s Lymphoma Disease in which malignant (cancer) cells form in the lymph system Type of cancer that develops in.
HAEMATOPOIETIC STEM ELL TRANSPLANTATION (HSCT) A process in which abnormal, malignant, or non- functioning marrow cells are replaced with normal marrow.
Tumors of the Bone By: Pretoria Hoyte Etiology: A tumor is a lump or mass of tissue that forms when cells divide uncontrollably. A growing tumor may.
Treatment. Phases of treatment Induction chemotherapy Postremission therapy *Initial goal: quickly induce CR *Therapy depends on patient age.
Why Are Biometric Screenings Important? Lisa Fernandez.
Hematopoietic Stem Cell Current Status and Future Directions
Hematopoietic Stem Cell Transplantation (HSCT)
HAEMATOPOIETIC STEM ELL TRANSPLANTATION (HSCT) A process in which abnormal, malignant, or non- functioning marrow cells are replaced with normal marrow.
Stem Cell Transplantation
RIC UCBT Transplantation of Umbilical Cord Blood from Unrelated Donors in Patients with Haematological Diseases using a Reduced Intensity Conditioning.
An Introduction to Bone Marrow Transplant
The Donor Perspective Catherine Burlton Title slide (option number 2)
GTP Scenario # 4 September 17,2005.
Autologous Peripheral Blood Stem Cell Rescue. Multiple Myeloma.
MLAB Hematology Keri Brophy-Martinez
Coordination (benign lesions)
EBMT Activity Survey Teams Patients Transplants
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Renal Transplant Patient Education
Human Health and Disease
Peripheral Blood Stem Cell Rescue. Multiple Myeloma.
EBMT Activity Survey Teams Patients Transplants
A young patient with multiple myeloma
PREDICTIVE FACTORS AFFECTING THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION USING RIC REGIMENS: EXPERIENCE FROM A SINGLE CENTRE Dott.ssa M. Medeot.
Leukemia.
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION for MULTIPLE MYELOMA
Peripheral Blood Stem Cell Rescue. Multiple Myeloma.
Multiple Myeloma Overview all transplants, autologous and allogeneic (period ) N=28.887
Letermovir(Prevymis™) Guidelines for Inpatient Use
Is There a Role for Autologous Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia? A Retrospective Analysis  Nicolas Novitzky, Valda.
Introduction. Title: Activities and Outcomes of Hematopoietic Cell Transplantation in Japan.
Systemic Toxoplasmosis Post Allogeneic Stem Cell Transplantation (Allo-SCT): Lessons Learned from HIV?  Marie von Lilienfeld-Toal, MD, Maria Gilleece,
The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management by Elias J. Anaissie, Tahsine.
by Lapo Alinari, and Kristie A. Blum
Presentation transcript:

Laboratory PLANNING - WORKUP Blood Bank Apheresis Immunology Respiratory Dental Cardiology Radiology

VIROLOGY  HEPATITIS A, B & C PROFILES  BRUCELLA, EPSTEIN BARR, HERPES,  CMV, VARICELLA AB’s  TOXOPLASMOSIS AB’s RADIOLOGY  CHEST X-RAY/PNS  CT SCANS PLANNING - WORKUP MOLECULAR BIOLOGY  BONE MARROW BX AND ASPIRATE  CHIMERISM  PCR AND CYTGENETICS FOR CML PATIENTS MICROBILOGY  URINALYSIS  URINE CULTURE  PREGNANCY TEST IF FEMALE OTHERS...  AUDIOMETRY IF REQUIRED  RESPIRATORY-PFT  DENTAL  CARDIOLOGY-EKG/ECHO LABORATORY TESTS  CBCD, PT, PTT, FIB  RF, HEP, AST, ALT, AP, LD, GLUC, UREA, MG, CA, ALB BLOOD BANK  DAT, HIV, HTLV, ABO  ABO ISO IF BLOOD GROUP MISMATCH

CONSENTS for Patient...  PermCath / Hickman cath  Mobilization  Apheresis  Allo PBSCT/Bone Marrow Transplant  High dose chemotherapy  Sterility  Consent for Trials if applicable CONSENTS for Donor...  Bone Marrow Harvest  Peripheral Stem cell Harvest  Stiff Quinton if required PLANNING - WORKUP

 PBPC Transplant  Bone Marrow Transplant  Cord Transplant  Harvest schedule TEACHING  Patient family SCHEDULING PLANNING - TRANSPLANT  Admission and Transplant Date

PROBLEMS ENCOUNTERED Patient and Family Education × Non-compliance × Family Interference × Cultural Issues

WARD CLERK APPOINTMENTS & BOOKING PATS LABS POST BMT W/UP BMT NURSE 1 LEADERBMT NURSE ORGANIZE & DISTRIBUTE BMT W/UP LOAD ORGANIZE BOOKING W/ OTHER UNIT DLI W/UP & F/UP NMA POST F/UP DISCUSS W/LOAD W/ BMT COOR & THE NEED DROP IN CLINIC POST BMT PTS W/UP SCHEDULE DONOR ASSESSMENT MOBILIZATION & APHERESIS ORGANIZE PROCEDURES IMMUNIZATIONS PHYSICIAN BMT CLINIC BMT NURSE CLINIC BMT COORDINATION BMT COORDINATOR PHYSICIAN BMT CLINIC FLOATING NURSE WITH MULTIPLE FUNCTIONS

= 15% increase = 33% increase = 37% increase ONCO ,2743,4352, ONCO55 ONCO57 ONCO72 ONCO73 ONCO ,2416,9705,080 ONCO75 ONCO76 ONCO78 TOTAL RES. ID BMT/CLINICS TREND 391 8, , SCT Teaching 4,0215,024 NURSE (BMT) 8,6158,078 Non Medical TOTAL 1, AUTOLOGOUS 2,8732,170 ALLOGENIC Jan-Sept PATIENT SEEN IN BMT CLINIC

1. Vital Signs 2. Weight 3. BMT Nurse Assessment 4. BMI (Body Mass Index) 5. Labs Required BMT LABS WORK-UP + CSA LEVEL UNTIL THE END OF TREATMENT BMT LABS WORK-UP + CSA LEVEL UNTIL THE END OF TREATMENT CMV ANTIGENEMIA + SHELL VIAL UP TO 120 DAYS POST TRANSPLANT CMV ANTIGENEMIA + SHELL VIAL UP TO 120 DAYS POST TRANSPLANT CHIMERISM AS PER PROTOCOL CHIMERISM AS PER PROTOCOL INTRATHECAL CHEMO 50days TRANSPLANT FOR HIGH RISK LEUKEMIA’S PATIENTS INTRATHECAL CHEMO 50days TRANSPLANT FOR HIGH RISK LEUKEMIA’S PATIENTS

1. Vital Signs 2. Weight 3. BMT Nurse Assessment 4. Labs Required BMT WORK-UP 5. IF MULTIPLE MYELOMA; TOTAL PROT, IMMUNOGLOBULIN QUANTITATION + IFE SERUM + URINE UP TO 120days Post BMT. 6. IF LYMPHOMA AS REQUIRED BY PHYSICIAN...

PHYSICIANS BMT COORDINATING TEAM NURSES IN AND OUT PATIENT IMMUNOLOGY & BLOOD BANK & APHERESIS ANGIO UNIT IV Nurse Staff RADIATION THERAPY UNIT O.RRADIOLOGY DMU & DSU STAFF PHYSICAL THERAPIST DIETICIAN SOCIAL WORKER OUT PATIENT CLINICS DENTAL, ECHO, PFT.